However, whether YPFS regulates the immune-related factor TSLP to attenuate the activation of the TSLP-STAT3 signaling pathway, thereby inhibits the formation of angiogenesis and exerts an anti-HCC effect remain unknown. The gene discussed is TSLP; the disease is hepatocellular carcinoma.